P2X7 Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune Encephalomyelitis
about
Molecular and functional properties of P2X receptors--recent progress and persisting challengesThe clearance of dying cells: table for twoOligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and UpdateThe Role of Astrocytes in Multiple Sclerosis ProgressionMyelin damage and repair in pathologic CNS: challenges and prospectsPurinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and deathP2X receptors as targets for the treatment of status epilepticusIon channels as drug targets in central nervous system disordersMicroglial P2Y12 deficiency/inhibition protects against brain ischemiaA model of ischemia-induced neuroblast activation in the adult subventricular zoneNeuronal and glial purinergic receptors functions in neuron development and brain diseaseCritical role of connexin 43 in secondary expansion of traumatic spinal cord injury.P2X ion channel receptors and inflammationThe Role of Purine Metabolites as DAMPs in Acute Graft-versus-Host DiseaseEffect of Lead (Pb) on Inflammatory Processes in the BrainThe astrocyte in multiple sclerosis revisitedPathophysiology of astroglial purinergic signallingAnti-prion activity of Brilliant Blue GOligodendrocytes: biology and pathologyP2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway.A safe, blood-brain barrier permeable triphenylmethane dye inhibits amyloid-β neurotoxicity by generating nontoxic aggregatesThe purine receptor P2X7R regulates the release of pro-inflammatory cytokines in human craniopharyngioma.Long-term consumption of caffeine-free high sucrose cola beverages aggravates the pathogenesis of EAE in mice.Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy.Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis.Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosisStrategies to limit dysmyelination during secondary degeneration following neurotraumaNon-synonymous single nucleotide polymorphisms in the P2X receptor genes: association with diseases, impact on receptor functions and potential use as diagnosis biomarkersMechanisms of axonal injury: internodal nanocomplexes and calcium deregulation.Protective Effects of Berberine on Oxygen-Glucose Deprivation/Reperfusion on Oligodendrocyte Cell Line (OLN-93).Contribution of pannexin1 to experimental autoimmune encephalomyelitis.Oligodendrocyte fate after spinal cord injury.Increased expression of cystine/glutamate antiporter in multiple sclerosisOligodendrocyte birth and death following traumatic brain injury in adult mice.ATP as a multi-target danger signal in the brain.Roles of white matter in central nervous system pathophysiologies.The axon-glia unit in white matter stroke: mechanisms of damage and recovery.P2 receptors and immunity.Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation.NLRP3 Inflammasome and MS/EAE.
P2860
Q24617046-4897E61F-8933-4F0F-BD26-83D14FD22AB2Q26753825-9C644DAD-5374-4730-ABA5-D44D755C1AAFQ26780518-75FDD2EB-42FF-4136-BF05-382AC7550685Q26782843-AF25915B-BD56-4FF3-AD0A-2D67589AC912Q26797407-60927184-8199-4E3B-BB31-1CE6F15AD87BQ26822468-EE0D0E1F-02EB-4176-BBF6-0F8F0D010B8AQ26823175-4D580AC9-F733-4487-A2B1-C676BADA626DQ27004533-175AB272-9D82-4981-8833-36BBFF3FD89CQ27309972-6503E7F4-768B-4299-BAF2-029411494C8EQ27349769-5C81609D-6C75-43CD-B10C-23237CD855E6Q27500377-6676AF28-151B-4D81-9CD7-E63CF461FD26Q27863423-260E9DCF-02F7-4784-8951-06D5D36DBF0CQ28066934-6688B7B8-59E2-440F-8149-925340C70B62Q28068647-A47A58E3-1D12-4BE3-8681-5C74EA8181E8Q28079973-C1CAD160-CCFE-47B0-B1C5-13C6CB903C73Q28283441-B823F609-DCD3-4471-8E0C-367F39193E7EQ28384801-0938ACE3-AE15-42ED-809F-8D755F56EA98Q28484054-20EB0E46-EF80-43D9-9A9D-308C5F48A249Q30051584-934C8188-805A-4A1F-BA5F-6FF2B4D85C00Q30409205-28E59180-0E25-4EC5-85C8-6E1B419EB71DQ30423892-21B376DF-004E-41E1-8A86-2B76AC6BC0B7Q33759124-67F4DEFB-73F6-472A-8E20-3528F27F5683Q33814065-5DEEB293-7C67-4DA4-883D-CCA50F5B3627Q33898338-30E65C7C-994C-4B52-8FF0-BE019224A748Q33980768-19A65B31-D2F4-47FC-8550-23276BE8EC71Q34081777-59603BA6-9FDE-491C-B775-DBD44D139B97Q34095396-15BA13C2-737F-4D09-91D8-A99E18599096Q34158330-97249BA8-0B66-4258-9EFB-EDD846CCD3EBQ34292220-F0453422-3E54-4F89-AD32-71AB3BA5B922Q34318643-9F6980F4-0C2A-4A46-93C4-C777BCBB68B4Q34864822-F896AA50-7418-4BAD-A24D-B6B502D7D269Q35006477-2EF91CBB-742D-4C0E-9F03-4247CE60EDF7Q35052754-338B8AB5-A9E4-49E4-8C7B-71A3BFB3810CQ35208769-EAB9FA6C-B5D5-4277-929C-DAD5F2C5A84EQ35545478-909667DD-9735-44DC-AF8E-E7931CD7D28EQ35846494-7DA8E6D2-FE51-4F74-8F4D-170E5DF8AA12Q35984483-D4B93270-E085-43FB-9F1D-A099A4B1C075Q36446067-95CB6300-C25E-4164-AFB8-26489AA65583Q36513651-0761F6D1-2651-4A30-B41F-5243E4CCBD0BQ36566053-6C06E07D-A8DA-4A8F-81BD-3096105542AE
P2860
P2X7 Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune Encephalomyelitis
description
im August 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 August 2007
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2007
@uk
name
P2X7 Receptor Blockade Prevent ...... l Autoimmune Encephalomyelitis
@en
P2X7 Receptor Blockade Prevent ...... l Autoimmune Encephalomyelitis
@nl
type
label
P2X7 Receptor Blockade Prevent ...... l Autoimmune Encephalomyelitis
@en
P2X7 Receptor Blockade Prevent ...... l Autoimmune Encephalomyelitis
@nl
prefLabel
P2X7 Receptor Blockade Prevent ...... l Autoimmune Encephalomyelitis
@en
P2X7 Receptor Blockade Prevent ...... l Autoimmune Encephalomyelitis
@nl
P2093
P50
P1476
P2X(7) receptor blockade preve ...... l autoimmune encephalomyelitis
@en
P2093
Amaia M Arranz
Estibaliz Etxebarria
Iratxe Torre
Rivka Ravid
P304
P356
10.1523/JNEUROSCI.0579-07.2007
P407
P50
P577
2007-08-01T00:00:00Z